Summary

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Executive Director, Manufacturing IT Planning & Strategy (Digital Transformation) to join our IOPS IT organization, leading the planning and governance behind our digital and automation transformation supporting GMP operations. Sitting within the Plan function of IOPS IT's Plan-Build-Run operating model, you will set the direction, governance, and investment strategy that Build and Run teams deliver and sustain — partnering with corporate IT and cross-functional leaders across the enterprise to drive fast, reliable, and compliant technology decisions at scale.

Job description

Build our future together

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Executive Director, Manufacturing IT Planning & Strategy (Digital Transformation) to join our IOPS IT organization, leading the planning and governance behind our digital and automation transformation supporting GMP operations. Sitting within the Plan function of IOPS IT's Plan-Build-Run operating model, you will set the direction, governance, and investment strategy that Build and Run teams deliver and sustain — partnering with corporate IT and cross-functional leaders across the enterprise to drive fast, reliable, and compliant technology decisions at scale.

When & where

Location: Troy, New York United States
Work model: 8am - 4:30pm, onsite
Travel percentage: 25% global to other manufacturing facilities

Discover your role

Establish technology governance, portfolio management, and demand management anchored in enterprise architecture standards, driving business and technology transformation through full portfolio visibility and fast technology decisions.
Lead large-scale IT and digital transformation programs, resolving constraints and redirecting priorities to deliver business outcomes.
Successfully take modern, cutting-edge technologies from plan to implementation, with reliability and security built in.
Deliver technology solutions in cGMP pharmaceutical or biotech manufacturing, aligning compliance, validation, and data integrity with every technology decision.
Communicate technology strategy into funded investment plans and manage budgets with a clear view of long-term operating impact.
Utilize interpersonal skills to collaborate across all organizational levels.

This role requires

Bachelor's degree in IT or a related field and have 18+ years of experience in IT and business operations/transformations, in a cGMP biotechnology/pharmaceutical environment. An equivalent combination of education and experience will be considered.

Requirements

Bachelor's degree in IT or a related field
18+ years of experience in IT and business operations/transformations
Experience in a cGMP biotechnology/pharmaceutical environment
Technology governance and portfolio management
Enterprise architecture standards
Large-scale IT and digital transformation program leadership
cGMP compliance, validation, and data integrity
Budget and investment planning
Strong interpersonal and cross-functional collaboration skills

Benefits

Annual bonuses
Incentive plans
Equity awards
Pension or retirement benefits
401(k) company match
Health and wellness programs
Fitness centers
Medical, Dental & Vision
Paid time off
Family support benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.